October 8, 2024
Press Release
Vividion Therapeutics Appoints Frank Poschen to Board of Directors
July 23, 2024
Press Release
Vividion Therapeutics to Expand with New Global Research and Development Center
April 25, 2024
Press Release
Vividion Therapeutics and Roche Jointly Publish Landmark Nature Paper on Clinical-Stage Covalent Allosteric Inhibitor of Werner Helicase (WRN)
April 12, 2024
Publications & Posters
Development and Characterization of Covalent Inhibitors of the RAS-PIK3CA interaction
April 3, 2024
Press Release
Bayer and Vividion Therapeutics to highlight advancing oncology portfolio at AACR 2024 Annual Meeting
